Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
142M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
19.3M
-
Shares change
-
-77.7K
-
Total reported value, excl. options
-
$15.6M
-
Value change
-
+$123K
-
Put/Call ratio
-
0
-
Number of buys
-
16
-
Number of sells
-
-15
-
Price
-
$0.81
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q1 2023
45 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q1 2023.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.3M shares
of 142M outstanding shares and own 13.62% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (4.78M shares), Knoll Capital Management, LLC (3.45M shares), FMR LLC (2.97M shares), Simplify Asset Management Inc. (2.38M shares), VANGUARD GROUP INC (855K shares), Alyeska Investment Group, L.P. (799K shares), Rock Springs Capital Management LP (781K shares), Point72 Asset Management, L.P. (720K shares), GEODE CAPITAL MANAGEMENT, LLC (361K shares), and CITIGROUP INC (353K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.